The future burden of Parkinson's disease.
作者信息
Rocca Walter A
机构信息
Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
出版信息
Mov Disord. 2018 Jan;33(1):8-9. doi: 10.1002/mds.27114. Epub 2017 Aug 7.
Abstract
摘要
相似文献
1
The future burden of Parkinson's disease.
Mov Disord. 2018 Jan;33(1):8-9. doi: 10.1002/mds.27114. Epub 2017 Aug 7.
2
Factors associated with the quality of life of subjects with Parkinson's disease and burden on their caregivers.
Neurologia. 2015 Jun;30(5):257-63. doi: 10.1016/j.nrl.2014.01.008. Epub 2014 Apr 3.
3
Symptom prevalence, severity and palliative care needs assessment using the Palliative Outcome Scale: a cross-sectional study of patients with Parkinson's disease and related neurological conditions.
Palliat Med. 2013 Sep;27(8):722-31. doi: 10.1177/0269216312465783. Epub 2012 Dec 3.
4
Validity and reliability of the PDCB: a tool for the assessment of caregiver burden in Parkinson's disease.
Int Psychogeriatr. 2013 Sep;25(9):1437-41. doi: 10.1017/S1041610213000586. Epub 2013 May 2.
5
The relationship between specific cognitive defects and burden of care in Parkinson's disease.
Int Psychogeriatr. 2016 Feb;28(2):275-81. doi: 10.1017/S1041610215001593. Epub 2015 Oct 5.
6
Burden among Parkinson's disease care givers for a community based study from India.
J Neurol Sci. 2015 Nov 15;358(1-2):276-81. doi: 10.1016/j.jns.2015.09.009. Epub 2015 Sep 4.
7
Parkinson's in the oldest old: Impact on estimates of future disease burden.
Parkinsonism Relat Disord. 2017 Sep;42:78-84. doi: 10.1016/j.parkreldis.2017.06.018. Epub 2017 Jun 27.
8
Quality of Life and Caregivers' Burden of Parkinson's Disease.
Neuroepidemiology. 2017;48(3-4):131-137. doi: 10.1159/000479031. Epub 2017 Jul 21.
9
Medication costs following subthalamic nucleus deep brain stimulation for Parkinson's disease.
Mov Disord. 2014 Feb;29(2):275-6. doi: 10.1002/mds.25504. Epub 2013 May 21.
10
The economic impact of Parkinson's disease.
Parkinsonism Relat Disord. 2007 Sep;13 Suppl:S8-S12. doi: 10.1016/j.parkreldis.2007.06.003. Epub 2007 Aug 16.
引用本文的文献
1
Toward a biological definition of neuronal and glial synucleinopathies.
Nat Med. 2025 Feb;31(2):396-408. doi: 10.1038/s41591-024-03469-7. Epub 2025 Jan 30.
2
The Expanding Burden of Neurodegenerative Diseases: An Unmet Medical and Social Need.
Aging Dis. 2024 Nov 9. doi: 10.14336/AD.2024.1071.
3
Co-Design of a Facilitated Self-Management Toolkit for People With Parkinson's Disease.
Health Expect. 2024 Dec;27(6):e70104. doi: 10.1111/hex.70104.
4
Prevalence of Parkinson's disease among adults aged 45 years and older in China: a cross-sectional study based on the China health and retirement longitudinal study.
BMC Public Health. 2024 May 2;24(1):1218. doi: 10.1186/s12889-024-18653-0.
5
Tackling Parkinson's Disease as a Global Challenge.
J Parkinsons Dis. 2023;13(8):1277-1280. doi: 10.3233/JPD-239005.
6
A Randomized Placebo-Controlled Study of a Transcranial Photobiomodulation Helmet in Parkinson's Disease: Post-Hoc Analysis of Motor Outcomes.
J Clin Med. 2023 Apr 13;12(8):2846. doi: 10.3390/jcm12082846.
7
The burden of Parkinson's disease in the Middle East and North Africa region, 1990-2019: results from the global burden of disease study 2019.
BMC Public Health. 2023 Jan 16;23(1):107. doi: 10.1186/s12889-023-15018-x.
8
«One Small Step for Mouse»: High CO Inhalation as a New Therapeutic Strategy for Parkinson's Disease.
Biomedicines. 2022 Nov 6;10(11):2832. doi: 10.3390/biomedicines10112832.
9
Change in the incidence of Parkinson's disease in a large UK primary care database.
NPJ Parkinsons Dis. 2022 Mar 15;8(1):23. doi: 10.1038/s41531-022-00284-0.
10
Application of Sebum Lipidomics to Biomarkers Discovery in Neurodegenerative Diseases.
Metabolites. 2021 Nov 29;11(12):819. doi: 10.3390/metabo11120819.
本文引用的文献
1
Projection of the prevalence of Parkinson's disease in the coming decades: Revisited.
Mov Disord. 2018 Jan;33(1):156-159. doi: 10.1002/mds.27063. Epub 2017 Jun 7.
2
Time, Sex, Gender, History, and Dementia.
Alzheimer Dis Assoc Disord. 2017 Jan-Mar;31(1):76-79. doi: 10.1097/WAD.0000000000000187.
3
Unchanged long-term rural-to-urban incidence ratio of Parkinson's disease.
Mov Disord. 2017 Mar;32(3):474-475. doi: 10.1002/mds.26862. Epub 2016 Nov 10.
4
Trends in the Incidence of Parkinson Disease-Reply.
JAMA Neurol. 2016 Dec 1;73(12):1498-1499. doi: 10.1001/jamaneurol.2016.3847.
5
Trends in the Incidence of Parkinson Disease.
JAMA Neurol. 2016 Dec 1;73(12):1497. doi: 10.1001/jamaneurol.2016.3844.
6
Time Trends in the Incidence of Parkinson Disease.
JAMA Neurol. 2016 Aug 1;73(8):981-9. doi: 10.1001/jamaneurol.2016.0947.
7
Trends in the Incidence of Parkinson Disease in the General Population: The Rotterdam Study.
Am J Epidemiol. 2016 Jun 1;183(11):1018-26. doi: 10.1093/aje/kwv271. Epub 2016 Apr 29.
8
Variations in Incidence and Prevalence of Parkinson's Disease in Taiwan: A Population-Based Nationwide Study.
Parkinsons Dis. 2016;2016:8756359. doi: 10.1155/2016/8756359. Epub 2016 Jan 19.
9
Time trends in the prevalence and incidence of Parkinson's disease in Taiwan: A nationwide, population-based study.
J Formos Med Assoc. 2016 Jul;115(7):531-8. doi: 10.1016/j.jfma.2015.05.014. Epub 2015 Jun 27.
10
Increasing age-adjusted male-to-female incidence ratio of Parkinson's disease.
Mov Disord. 2015 Feb;30(2):286-8. doi: 10.1002/mds.26098. Epub 2014 Dec 5.
Zotero 插件